Department of Chemistry, Seoul National University, Seoul, Republic of Korea.
Department of Chemistry, Sejong University, Seoul, Republic of Korea.
J Neurochem. 2021 Mar;156(6):967-978. doi: 10.1111/jnc.15150. Epub 2020 Sep 16.
The lysosomal membrane protein Niemann-Pick type C1 (NPC1) and Niemann-Pick type C2 (NPC2) are main players of cholesterol control in the lysosome and it is known that the mutation on these proteins leads to the cholesterol trafficking-related neurodegenerative disease, which is called the NPC disease. The mutation R518W or R518Q on the NPC1 is one of the type of disease-related mutation that causes cholesterol transports to be cut in half, which results in the accumulation of cholesterol and lipids in the late endosomal/lysosomal compartment of the cell. Even though there has been significant progress with understanding the cholesterol transport by NPC1 in combination with NPC2, especially after the structural determination of the full-length NPC1 in 2016, many details such as the interaction of the full-length NPC1 with the NPC2, the molecular motions responsible for the cholesterol transport during and after this interaction, and the structure and the function relations of many mutations are still not well understood. In this study, we report the extensive molecular dynamics simulations in order to gain insight into the structure and the dynamics of NPC1 lumenal domain for the cholesterol transport and the disease behind the mutation (R518W). It was found that the mutation induces a structural shift of the N-terminal domain, toward the loop region in the middle lumenal domain, which is believed to play a central role in the interaction with NPC2 protein, so the interaction with the NPC2 protein might be less favorable compared to the wild NPC1. Also, the simulation indicates the possible re-orientation of the N-terminal domain with both the wild and the R518W-mutated NPC1 after receiving the cholesterol from the NPC2 that align to form an internal tunnel, which is a possible pose for further action in cholesterol trafficking. We believe the current study can provide a better understanding of the cholesterol transport by NPC1 especially the role of NTD of NPC1 in combination with NPC2 interactions.
溶酶体膜蛋白尼曼-匹克 C1 型(NPC1)和尼曼-匹克 C2 型(NPC2)是溶酶体中胆固醇控制的主要参与者,已知这些蛋白质的突变导致胆固醇转运相关的神经退行性疾病,称为 NPC 疾病。NPC1 上的突变 R518W 或 R518Q 是导致胆固醇转运减少一半的疾病相关突变类型之一,导致胆固醇和脂质在细胞的晚期内体/溶酶体隔室中积累。尽管在 NPC1 与 NPC2 结合的胆固醇转运方面已经取得了重大进展,尤其是在 2016 年确定了全长 NPC1 的结构之后,许多细节,如全长 NPC1 与 NPC2 的相互作用、在此相互作用期间和之后负责胆固醇转运的分子运动,以及许多突变的结构和功能关系,仍然了解得不够充分。在这项研究中,我们报告了广泛的分子动力学模拟,以深入了解 NPC1 腔内腔域的结构和动力学,以及突变(R518W)背后的胆固醇转运和疾病。研究发现,突变诱导 N 端结构域发生结构移位,向中间腔内腔域的环区移动,这被认为在与 NPC2 蛋白的相互作用中起核心作用,因此与 NPC2 蛋白的相互作用可能不如野生型 NPC1 有利。此外,模拟表明,野生型和 R518W 突变 NPC1 在从 NPC2 接收胆固醇后,N 端结构域可能会重新定向,两者对齐形成一个内部隧道,这可能是胆固醇转运进一步作用的一种可能构象。我们相信,当前的研究可以更好地理解 NPC1 介导的胆固醇转运,特别是 NPC1 的 NTD 在与 NPC2 相互作用中的作用。